"Antidiarrheals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.
Descriptor ID |
D000930
|
MeSH Number(s) |
D27.505.954.483.161
|
Concept/Terms |
Antidiarrheals- Antidiarrheals
- Antidiarrheal Drugs
- Drugs, Antidiarrheal
- Antidiarrheal Agents
- Agents, Antidiarrheal
Antiperistaltic Agents- Antiperistaltic Agents
- Agents, Antiperistaltic
- Antiperistaltics
- Antiperistaltic Drugs
- Drugs, Antiperistaltic
|
Below are MeSH descriptors whose meaning is more general than "Antidiarrheals".
Below are MeSH descriptors whose meaning is more specific than "Antidiarrheals".
This graph shows the total number of publications written about "Antidiarrheals" by people in this website by year, and whether "Antidiarrheals" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antidiarrheals" by people in Profiles.
-
Liang D, Ma J, Wei B. Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness. Sci Rep. 2021 01 28; 11(1):2605.
-
Toropov AA, Toropova AP, Benfenati E, Gini G, Leszczynska D, Leszczynski J, De Nucci G. QSAR models for inhibitors of physiological impact of Escherichia coli that leads to diarrhea. Biochem Biophys Res Commun. 2013 Mar 08; 432(2):214-25.
-
Zhou Y, Sridhar R, Shan L, Sha W, Gu X, Sukumar S. Loperamide, an FDA-approved antidiarrhea drug, effectively reverses the resistance of multidrug resistant MCF-7/MDR1 human breast cancer cells to doxorubicin-induced cytotoxicity. Cancer Invest. 2012 Feb; 30(2):119-25.